Genome & Company Market Cap

Genome & Company has a market cap or net worth of 78.18 billion as of May 13, 2025. Its market cap has decreased by -35.14% in one year.

Market Cap

78.18B

Enterprise Value

80.91B

Revenue

27.74B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,515.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 78.18B, an increase of 8.77%. That is a compound annual growth rate of 1.33%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	78.96B	-7.33%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	361.77T
SK hynix	130.99T
LG Energy Solution	74.41T
Samsung Biologics	74.02T
Hyundai Motor Company	41.61T
Hanwha Aerospace	39.92T
HD Hyundai Heavy Industries	36.66T
Kia Corporation	35.16T

Market Cap Rankings